Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Soft Tissue Tumor, Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03009201
What this trial is testing

Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery

Who this might be right for
Advanced Soft Tissue SarcomaLocally Advanced AngiosarcomaLocally Advanced Leiomyosarcoma+24 more
OHSU Knight Cancer Institute 16
Very early researchNot Yet RecruitingNCT07066436
What this trial is testing

ImmunoMRI for Assessment of Tumor-associated Macrophages

Who this might be right for
DLBCL - Diffuse Large B Cell Lymphoma
Medical University of Vienna 60
Not applicableStudy completedNCT03655587
What this trial is testing

Impact of an Orthotic Intervention in Children With Peripheral Neuropathy

Who this might be right for
Gait, Drop FootChemotherapy-induced Peripheral NeuropathyAcute Lymphocytic Leukemia, Pediatric+2 more
Children's Hospitals and Clinics of Minnesota 27
Testing effectiveness (Phase 2)Study completedNCT00006014
What this trial is testing

SU5416 in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
National Cancer Institute (NCI) 45
Not applicableLooking for participantsNCT07793006
What this trial is testing

New Approaches for the Diagnosis of Lymphoma and Multicentric Castleman Disease

Who this might be right for
HIVKaposi Sarcoma Herpesvirus -Associated Multicentric Castleman DiseaseHodgkin Lymphoma+3 more
Indiana University 500
Testing effectiveness (Phase 2)Study completedNCT00001114
What this trial is testing

The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 90
Not applicableLooking for participantsNCT07727434
What this trial is testing

Stress and Anxiety Before Biopsy, After Biopsy Results, and During Treatment in Patients With Suspected Bone or Soft Tissue Cancer

Who this might be right for
Bone NeoplasmsSoft Tissue NeoplasmsAnxiety+1 more
Istanbul University 100
Testing effectiveness (Phase 2)Ended earlyNCT01104298
What this trial is testing

Doxorubicin vs. Trabectedin Plus Doxorubicin in Non Operable and/or Metastatic STS

Who this might be right for
Sarcoma
Grupo Espanol de Investigacion en Sarcomas 115
Not applicableNo Longer AvailableNCT00210665
What this trial is testing

Provide Access to Trabectedin in Participants With Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Persistent or Recurrent Disease and Who Are Not Expected to Benefit From Currently Available Standard of Care Treatment

Who this might be right for
Sarcoma
Janssen Research & Development, LLC
Testing effectiveness (Phase 2)Looking for participantsNCT07169344
What this trial is testing

Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma (Excluding GIST)Soft Tissue Sarcoma AdultSoft Tissue Sarcoma of the Trunk and Extremities+6 more
Oslo University Hospital 110
Testing effectiveness (Phase 2)Looking for participantsNCT07255963
What this trial is testing

Pirtobrutinib, Lisaftoclax, and Rituximab in the Treatment of R/R DLBCL

Who this might be right for
DLBCL - Diffuse Large B Cell Lymphoma
The First Affiliated Hospital of Soochow University 29
Testing effectiveness (Phase 2)Looking for participantsNCT06667544
What this trial is testing

RNK08954 in Subjects With Advanced Solid Tumors With KRAS ((Kirsten Rat Sarcoma) G12D Mutation

Who this might be right for
KRAS G12D Mutation
Ranok Therapeutics (Hangzhou) Co., Ltd. 152
Testing effectiveness (Phase 2)Active Not RecruitingNCT05071209
What this trial is testing

Elimusertib for the Treatment of Relapsed or Refractory Solid Tumors

Who this might be right for
Recurrent Alveolar RhabdomyosarcomaRecurrent Ewing SarcomaRecurrent Lymphoma+5 more
National Cancer Institute (NCI) 31
Testing effectiveness (Phase 2)Looking for participantsNCT07125183
What this trial is testing

Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

Who this might be right for
Sarcoma
University of Colorado, Denver 20
Testing effectiveness (Phase 2)Ended earlyNCT02575066
What this trial is testing

Clinical Study of Concurrent Pazopanib and Radiotherapy for Non-metastatic Sarcoma Patients

Who this might be right for
SarcomaSoft Tissue Sarcomas
The Netherlands Cancer Institute 25
Not applicableStudy completedNCT00026754
What this trial is testing

Eligibility Screening for the NIH Intramural Research Program Clinical Protocols

Who this might be right for
Breast CancerProstate CancerLung Cancer+2 more
National Cancer Institute (NCI) 19,522
Large-scale testing (Phase 3)Looking for participantsNCT06345729
What this trial is testing

Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

Who this might be right for
Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 600
Testing effectiveness (Phase 2)Study completedNCT00515931
What this trial is testing

Radiation Therapy as Palliative Treatment of GIST

Who this might be right for
Sarcoma
Heikki Joensuu 25
Early research (Phase 1)UnknownNCT05487651
What this trial is testing

Allogeneic NK T-Cells Expressing CD19 Specific CAR in B-Cell Malignancies

Who this might be right for
NHL, Relapsed, AdultB-cell LymphomaB-cell Leukemia+4 more
Athenex, Inc. 36
Early research (Phase 1)Looking for participantsNCT06957431
What this trial is testing

Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma

Who this might be right for
Advanced LeiomyosarcomaAdipocytic SarcomaAdvanced Liposarcoma
Washington University School of Medicine 18
Next Page